Editor's Corner

On Monday evening we'll be announcing this year's Fierce 15 at BIO in Philadelphia. We'll run the list in a special issue slated for Tuesday morning. If you can, please come by FierceBiotech's event. You can sign up in advance -- as more than 300 attendees have already done -- or sign in at the event. Either way, we'd like as many of our more than 35,000 readers to be on hand as possible as we celebrate companies that have been making 2005 a watershed year in their development. And feel free to offer suggestions for 2006. A preliminary list is already underway. - John Carroll

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.